Evozym Biologics Announces Changes To Board Of Directors
LEWES, Del., June 24, 2014 (GLOBE NEWSWIRE) -- Evozym Biologics, Inc. ("Evozym" or the "Company") today announced that Dr. Marc Hertz and Dr. Jay Cullen have joined its Board of Directors.
Dr. Hertz, who was also named Evozym's Chairman, brings to the Company more than 20 years of experience in the field of biotechnology and immunology. Formerly CEO of Pharmexa, Inc. and Managing Director of Birdrock Biotech Consultancy, Dr. Hertz is currently Chairman of Mutimeric Biotherapeutics and CEO of GRI Bio, Inc. He is a graduate of Bowdoin College with a BA in Biology, and holds a doctorate degree in Immunology from the University of Colorado Anschutz Medical Campus.
Help employers find you! Check out all the jobs and post your resume.